An observational study in Vascular Access Port and Patient Satisfaction, sponsored by pfm medical gmbh. Completed at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-04-05.
Sponsored by pfm medical gmbh · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 22 studies in Patient Satisfaction with a site in Germany — 3 open to participants now, 3 under way, none of them phase 3. Patient Satisfaction · Germany.
Among the 22 studies in Patient Satisfaction with a site in Germany, this one is the 5th largest by enrollment of the 12 observational ones that give a count, is one of 4 that started in 2022, is one of 12 observational ones, and was the 14th registered.
882 studies on the registry are indexed under Patient Satisfaction; 205 are open to participants now.
Browse Patient Satisfaction studies →3 of the 22 studies in Patient Satisfaction with a site in Germany are open now. Recruiting first, the newest first:
LMU Klinikum · Sites in Germany
Ages 18–80
Augenklinik Ahaus G + H GmbH & Co. KG · Sites in Germany
Ages 22–85
Tobias Schreiber · Sites in Germany
Ages 18+
A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →
Of the 102 Patient Satisfaction studies recruiting now, 63 (62%) set no upper age limit and 31 (30%) stop at 75 or younger; 14 take children under 18; 26 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
22 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 4 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 149 is close to the median of 150 across 227 observational studies indexed under Patient Satisfaction.
Median enrollment 123 across the 10 interventional studies, 116 across the 12 observational. Of the 16 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
7 of 22 have an industry lead sponsor. The 10 most frequent:
pfm medical gmbh is the lead sponsor of 8 studies on the registry; none are open to participants now.
pfm medical gmbh has 1 study filed under Patient Satisfaction — fewer than ten, so there is no comparison to draw.
1 of the studies in Patient Satisfaction with a site in Germany that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07424482Tobias SchreiberEducational Video to Improve Understanding and Reduce Anxiety in Heart Attack Patients | 2027-09-01 |
Add it to your calendar (.ics) → With an account.
Among the 22 studies in Patient Satisfaction with a site in Germany, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Prospective, monocentric, non-randomised, observational post-market clinical follow-up study in Germany to obtain post-market information on the pfmmedical ports with a follow-up (FU) of 6 months. The focus is on patient reported satisfaction, clinical application, and complication rates.
150 patients requiring repeated vascular access
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Port implantation for continous vascular access.
Device: pfmmedical implantable vascular access ports
Implantion of an implantable vascular access port which facilitates repeated vascular access intended for the delivery of medications, intravenous fluids, parenteral nutrition solutions or blood products and blood sampling using a Huber needle.
Also known as: Jet Port® Plus II Contrast, T-Port Contrast, T-Port Low Profile Contrast
Patients satisfaction
The study hypothesis is that the patients' satisfaction after the study intervention is not worse than the satisfaction identified in the current literature. Satisfaction is determined using the patient questionnaire (6 months after implantation). The following 4 domains of the validated questionnaire by Nagel et.al., 2012 are considered as relevant for the clinical outcome: * Overall, how satisfied are you with the port system? * In a similar situation, would you choose the port again? * How satisfied are you with the cosmetic result? * Does the port cause pain?
Time frame: 6 months after port implantation
Plan to share: No
Ran from Apr 2022 to primary completion in Mar 2023, 10 months.
Of 113 observational studies under Patient Satisfaction, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 45. This study's 10 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
pfm medical gmbh